Taysha Gene Therapies Inc (TSHA)
2.37
-0.11
(-4.44%)
USD |
NASDAQ |
May 08, 16:00
2.36
-0.01
(-0.42%)
After-Hours: 20:00
Taysha Gene Therapies Market Cap: 443.23M for May 8, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 07, 2024 | 463.81M |
May 06, 2024 | 489.99M |
May 03, 2024 | 480.64M |
May 02, 2024 | 482.51M |
May 01, 2024 | 452.58M |
April 30, 2024 | 454.45M |
April 29, 2024 | 458.19M |
April 26, 2024 | 446.97M |
April 25, 2024 | 430.14M |
April 24, 2024 | 439.49M |
April 23, 2024 | 473.16M |
April 22, 2024 | 460.06M |
April 19, 2024 | 424.53M |
April 18, 2024 | 450.71M |
April 17, 2024 | 458.19M |
April 16, 2024 | 481.57M |
April 15, 2024 | 497.47M |
April 12, 2024 | 549.83M |
April 11, 2024 | 602.20M |
April 10, 2024 | 587.24M |
April 09, 2024 | 553.57M |
April 08, 2024 | 501.21M |
April 05, 2024 | 501.21M |
April 04, 2024 | 501.21M |
April 03, 2024 | 508.69M |
Date | Value |
---|---|
April 02, 2024 | 506.82M |
April 01, 2024 | 531.13M |
March 28, 2024 | 536.74M |
March 27, 2024 | 592.85M |
March 26, 2024 | 572.28M |
March 25, 2024 | 572.28M |
March 22, 2024 | 607.81M |
March 21, 2024 | 579.76M |
March 20, 2024 | 553.57M |
March 19, 2024 | 420.79M |
March 18, 2024 | 398.23M |
March 15, 2024 | 430.01M |
March 14, 2024 | 400.09M |
March 13, 2024 | 422.53M |
March 12, 2024 | 420.66M |
March 11, 2024 | 437.49M |
March 08, 2024 | 471.14M |
March 07, 2024 | 471.14M |
March 06, 2024 | 506.66M |
March 05, 2024 | 523.49M |
March 04, 2024 | 560.88M |
March 01, 2024 | 603.88M |
February 29, 2024 | 590.79M |
February 28, 2024 | 493.57M |
February 27, 2024 | 458.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
37.87M
Minimum
Jun 28 2023
1.199B
Maximum
Jan 20 2021
427.96M
Average
340.27M
Median
Nov 29 2023
Market Cap Benchmarks
Aquestive Therapeutics Inc | 226.13M |
Lifecore Biomedical Inc | 203.60M |
Relmada Therapeutics Inc | 116.17M |
ACADIA Pharmaceuticals Inc | 2.813B |
Cyclacel Pharmaceuticals Inc | 3.098M |
Market Cap Related Metrics
PS Ratio | 16.88 |
Price to Book Value | 5.915 |
Price | 2.37 |
Earnings Yield | -56.31% |